Canaccord Genuity Maintains Hold on Veracyte, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 54.8%

Neg 0% Neu 0% Pos 54.8%

Canaccord Genuity analyst Kyle Mikson maintains Veracyte (NASDAQ:VCYT) with a Hold and raises the price target from $42 to $60.